Aperam S.A. Just Missed Revenue By 10%: Here's What Analysts Think Will Happen Next

It's been a good week for Aperam S.A. (AMS:APAM) shareholders, because the company has just released its latest quarterly results, and the shares gained 2.9% to €30.74. Revenues were €1.4b, 10% below analyst expectations, although losses didn't appear to worsen significantly, with a per-share statutory loss of €3.17 being in line with what the analysts forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Taking into account the latest results, the consensus forecast from Aperam's nine analysts is for revenues of €6.85b in 2026. This reflects a decent 11% improvement in revenue compared to the last 12 months. Aperam is also expected to turn profitable, with statutory earnings of €2.80 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of €7.08b and earnings per share (EPS) of €3.22 in 2026. From this we can that sentiment has definitely become more bearish after the latest results, leading to lower revenue forecasts and a real cut to earnings per share estimates.

Check out our latest analysis for Aperam

Despite the cuts to forecast earnings, there was no real change to the €31.26 price target, showing that the analysts don't think the changes have a meaningful impact on its intrinsic value. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Aperam at €37.00 per share, while the most bearish prices it at €25.00. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The period to the end of 2026 brings more of the same, according to the analysts, with revenue forecast to display 8.4% growth on an annualised basis. That is in line with its 8.1% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 3.4% annually. So it's pretty clear that Aperam is forecast to grow substantially faster than its industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. They also downgraded Aperam's revenue estimates, but industry data suggests that it is expected to grow faster than the wider industry. The consensus price target held steady at €31.26, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Aperam analysts - going out to 2027, and you can see them free on our platform here.

It might also be worth considering whether Aperam's debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.